新規登録 | ログイン | FAQ      [?] 

Schizophrenia Research

最近発刊の雑誌の目次より: Schizophrenia Research © Elsevier
  • Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 89-96.
    by U Heresco-Levy, DC Javitt
  • Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 97-100.
    by MR Louza, AP Marques, H Elkis, D Bassitt, M Diegoli, WF Gattaz
  • Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 101-113.
    by PD Harvey, H Meltzer, GM Simpson, SG Potkin, A Loebel, C Siu, SJ Romano
  • Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 115-124.
    by DJ Kavanagh, G Waghorn, L Jenner, DC Chant, V Carr, M Evans, H Herrman, A Jablensky, JJ Mcgrath
  • First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 125-135.
    by Research HGDH Group, AI Green, MF Tohen, RM Hamer, SM Strakowski, JA Lieberman, I Glick, Scott
  • Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 137-142.
    by DR Heitmiller, PC Nopoulos, NC Andreasen
  • Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 143-150.
    by PF Buckley, JM Goldstein, RA Emsley
  • Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 151-157.
    by M Zink, A Schmitt, B May, B Muller, T Demirakca, DF Braus, FA Henn
  • Clozapine's effects on body weight and resting metabolic rate: a case series
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 159-162.
    by RM Procyshyn, A Chau, G Tse
  • Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 163-167.
    by RA Lasser, L Mao, G Gharabawi
  • Sex, ethnicity, and antipsychotic medication use in patients with psychosis
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 169-175.
    by LM Arnold, SM Strakowski, ML Schwiers, J Amicone, DE Fleck, KB Corey, JE Farrow
  • Secretin for refractory schizophrenia
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 177-181.
    by BB Sheitman, MB Knable, LF Jarskog, M Chakos, LH Boyce, J Early, JA Lieberman
  • Secretin in a patient with treatment-resistant schizophrenia and prominent autistic features
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 183-186.
    by SS Alamy, LF Jarskog, BB Sheitman, JA Lieberman
  • The effects of olanzapine on sensory gating in healthy participants
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 187-189.
    by CA Carroll, BF O'Donnell, A Shekhar, WP Hetrick
  • Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 191-192.
    by KP Su, HY Lane, CL Chuang, KP Chen, WW Shen
  • An association study of the neurotensin receptor gene with schizophrenia and clozapine response
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 193-195.
    by P Huezo-Diaz, MJ Arranz, J Munro, S Osborne, A Makoff, RW Kerwin, J Austin, M O'Donovan
  • Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 197-198.
    by MC Mauri, LS Volonteri, A Fiorentini, G Invernizzi, T Nerini, M Baldi, SR Bareggi
  • Treatment of tardive pharyngolaryngeal dystonia with olanzapine
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 199-200.
    by BJ Havaki-Kontaxaki, VP Kontaxakis, GN Christodoulou
  • Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine
    Schizophrenia Research, Vol. 66, No. 2. (1 February 2004), pp. 201-202.
    by KH Littrell, RG Petty, NM Hilligoss, CD Kirshner, CG Johnson
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/els-09209964

    RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.